Which test best predicts chemo risks in seniors? new study aims to find out

NCT ID NCT07163169

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at three simple tests—CARG, G8, and a frailty scale—to see which one best predicts chemotherapy side effects in cancer patients aged 65 and older. Researchers will assess 150 patients before they start chemo and track side effects during treatment. The goal is to find the most accurate tool to help doctors make safer treatment decisions for older adults.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors choose the best screening tool to predict chemotherapy side effects in older adults, leading to safer and more personalized cancer treatment.

What could go wrong

This is an observational study, not a treatment trial, so it won't directly improve outcomes. The results may not apply to all cancer types or chemotherapy regimens.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ONCOLOGY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Çanakkale Onsekiz Mart Univercity

    Çanakkale, 17020, Turkey (Türkiye)